Subscribe to RSS
DOI: 10.1055/s-0036-1586502
Morbidity and Mortality in Small-for-Gestational-Age Infants: A Secondary Analysis of Nine MFMU Network Studies
Publication History
13 April 2016
23 June 2016
Publication Date:
17 August 2016 (online)
Abstract
Objective To compare the neonatal morbidity and mortality among small-for-gestational-age (SGA; birth weight < 10% for estimated gestational age [EGA]) versus appropriate-for-gestational-age (AGA; birth weight at 10–89%) newborns.
Methods Data from nine Maternal-Fetal Medicine Units Network studies were used and included nonanomalous singletons at 24 weeks or more and birth weight < 90% for EGA. Using multivariable analysis, we compared the morbidity and mortality between SGA and AGA. Random-effect logistic regressions were utilized with adjustment for 10 variables.
Results Among the nine studies 71,744 singletons met the inclusion criteria, with 13% (n = 9,415) SGA and 87% (n = 62,329) AGA. Among SGA, the likelihood of stillbirth (8.8 vs. 2.5 per 1,000 births; adjusted odds ratio [aOR] 3.98, 95% confidence interval [CI]: 2.92–5.42) and neonatal mortality (14.0 vs. 5.5 per 1,000 births; aOR 3.18, 95% CI: 2.55–3.95) was threefold higher compared with AGA. For the subgroup of newborns of EGA of 32 weeks or more, SGA, compared with AGA, had significantly higher risk of stillbirth (aOR 3.32, 95% CI: 2.16–5.12) and neonatal mortality (aOR 2.50; 95% CI: 1.38–4.54). From 35 weeks onward, the risk of stillbirth among SGA is almost four times higher than for AGA.
Conclusion The risk of stillbirth and neonatal mortality is significantly higher with SGA than with AGA. Modification in practice or new management schema may be warranted.
-
References
- 1 Bukowski R, Hansen NI, Willinger M , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Stillbirth Collaborative Research Network. Fetal growth and risk of stillbirth: a population-based case-control study. PLoS Med 2014; 11 (4) e1001633 DOI: 10.1371/journal.pmed.1001633.
- 2 Pilliod RA, Cheng YW, Snowden JM, Doss AE, Caughey AB. The risk of intrauterine fetal death in the small-for-gestational-age fetus. Am J Obstet Gynecol 2012; 207 (4) 318.e1-318.e6
- 3 Trudell AS, Cahill AG, Tuuli MG, Macones GA, Odibo AO. Risk of stillbirth after 37 weeks in pregnancies complicated by small-for-gestational-age fetuses. Am J Obstet Gynecol 2013; 208 (5) 376.e1-376.e7
- 4 Unterscheider J, Daly S, Geary MP , et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol 2013; 208 (4) 290.e1-290.e6
- 5 Chauhan SP, Taylor M, Shields D, Parker D, Scardo JA, Magann EF. Intrauterine growth restriction and oligohydramnios among high-risk patients. Am J Perinatol 2007; 24 (4) 215-221
- 6 Dashe JS, McIntire DD, Lucas MJ, Leveno KJ. Effects of symmetric and asymmetric fetal growth on pregnancy outcomes. Obstet Gynecol 2000; 96 (3) 321-327
- 7 McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340 (16) 1234-1238
- 8 Maggio L, Dahlke JD, Mendez-Figueroa H, Albright CM, Chauhan SP, Wenstrom KD. Perinatal outcomes with normal compared with elevated umbilical artery systolic-to-diastolic ratios in fetal growth restriction. Obstet Gynecol 2015; 125 (4) 863-869
- 9 Chen HY, Chauhan SP, Ward TC, Mori N, Gass ET, Cisler RA. Aberrant fetal growth and early, late, and postneonatal mortality: an analysis of Milwaukee births, 1996–2007. Am J Obstet Gynecol 2011; 204 (3) 261.e1-261.e10
- 10 American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol 2013; 121 (5) 1122-1133
- 11 Berkley E, Chauhan SP, Abuhamad A ; Society for Maternal-Fetal Medicine Publications Committee. Doppler assessment of the fetus with intrauterine growth restriction. Am J Obstet Gynecol 2012; 206 (4) 300-308
- 12 Spong CY, Mercer BM, D'alton M, Kilpatrick S, Blackwell S, Saade G. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011; 118 (2, Pt 1): 323-333
- 13 Getahun D, Ananth CV, Kinzler WL. Risk factors for antepartum and intrapartum stillbirth: a population-based study. Am J Obstet Gynecol 2007; 196 (6) 499-507
- 14 Geva R, Eshel R, Leitner Y, Fattal-Valevski A, Harel S. Verbal short-term memory span in children: long-term modality dependent effects of intrauterine growth restriction. J Child Psychol Psychiatry 2008; 49 (12) 1321-1330
- 15 Smedler AC, Faxelius G, Bremme K, Lagerström M. Psychological development in children born with very low birth weight after severe intrauterine growth retardation: a 10-year follow-up study. Acta Paediatr 1992; 81 (3) 197-203
- 16 Jacobsson B, Ahlin K, Francis A, Hagberg G, Hagberg H, Gardosi J. Cerebral palsy and restricted growth status at birth: population-based case-control study. BJOG 2008; 115 (10) 1250-1255
- 17 Paulson JF, Chauhan SP, Hill JB, Abuhamad AZ. Severe small size for gestational age and cognitive function: catch-up phenomenon possible. Am J Obstet Gynecol 2012; 207 (2) 119.e1-119.e5
- 18 Marrs CC, Mendez-Figueroa H, Hammad IA, Chauhan SP. Differential morbidity in preterm small versus appropriate for gestational age: perhaps unverifiable. Am J Perinatol 2015; 32 (13) 1251-1256
- 19 Sibai BM, Caritis SN, Thom E , et al; The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329 (17) 1213-1218
- 20 Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D ; NICHD Maternal Fetal Medicine Units Network. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996; 87 (5, Pt 1): 643-648
- 21 Caritis S, Sibai B, Hauth J , et al; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998; 338 (11) 701-705
- 22 Meis PJ, Klebanoff M, Thom E , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348 (24) 2379-2385
- 23 Landon MB, Hauth JC, Leveno KJ , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004; 351 (25) 2581-2589
- 24 Rouse DJ, Hirtz DG, Thom E , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (9) 895-905
- 25 Wapner RJ, Sorokin Y, Thom EA , et al; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006; 195 (3) 633-642
- 26 Dizon-Townson D, Miller C, Sibai B , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106 (3) 517-524
- 27 Owen J, Yost N, Berghella V , et al; National Institute of Child Health and Human Development, Maternal-Fetal Medicine Units Network. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 2001; 286 (11) 1340-1348
- 28 Bottoms SF, Paul RH, Iams JD , et al; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Obstetric determinants of neonatal survival: influence of willingness to perform cesarean delivery on survival of extremely low-birth-weight infants. Am J Obstet Gynecol 1997; 176 (5) 960-966
- 29 Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87 (2) 163-168
- 30 Raghunathan TW, Lepkowksi JM, Van Hoewyk J, Solenbeger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 2001; 27: 85-95
- 31 Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991; 10 (4) 585-598
- 32 The American College of Obstetricians and Gynecologists. Practice bulletin no. 145: antepartum fetal surveillance. Obstet Gynecol 2014; 124 (1) 182-192
- 33 Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev 2013; 11 (11) CD007529 DOI: 10.1002/14651858.CD007529.pub2.
- 34 Tyson JE, Kennedy K, Broyles S, Rosenfeld CR. The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival?. Pediatrics 1995; 95 (4) 534-538
- 35 Gilbert WM, Danielsen B. Pregnancy outcomes associated with intrauterine growth restriction. Am J Obstet Gynecol 2003; 188 (6) 1596-1599 , discussion 1599–1601
- 36 Tröger B, Göpel W, Faust K , et al; German Neonatal Network. Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network. Pediatr Infect Dis J 2014; 33 (3) 238-243
- 37 Erel CT, Dane B, Calay Z, Kaleli S, Aydinli K. Apoptosis in the placenta of pregnancies complicated with IUGR. Int J Gynaecol Obstet 2001; 73 (3) 229-235
- 38 Regnault TR, de Vrijer B, Galan HL, Wilkening RB, Battaglia FC, Meschia G. Development and mechanisms of fetal hypoxia in severe fetal growth restriction. Placenta 2007; 28 (7) 714-723
- 39 Malhotra A, Sasi A, Miller SL, Jenkin G, Polglase GR. The efficacy of surfactant replacement therapy in the growth-restricted preterm infant: what is the evidence?. Front Pediatr 2014; 2: 118
- 40 Christensen RD, Yoder BA, Baer VL, Snow GL, Butler A. Early-onset neutropenia in small-for-gestational-age infants. Pediatrics 2015; 136 (5) e1259-e1267
- 41 Rosenberg A. The IUGR newborn. Semin Perinatol 2008; 32 (3) 219-224
- 42 Longo S, Borghesi A, Tzialla C, Stronati M. IUGR and infections. Early Hum Dev 2014; 90 (Suppl. 01) S42-S44
- 43 Carr R, Brocklehurst P, Doré CJ, Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet 2009; 373 (9659): 226-233
- 44 Royal College of Obstetricians & Gynaecologists. The investigation and management of the small-for-gestational-age fetus. RCOG Green-Top Guidelines No. 31. 2013
- 45 RCPI. Fetal growth restriction—recognition, diagnosis and management-No 28. RCPI Clinical Practice Guidelines; 2014
- 46 Lausman A, Kingdom J, Gagnon R , et al; Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can 2013; 35 (8) 741-757
- 47 Chauhan SP, Beydoun H, Chang E , et al. Prenatal detection of fetal growth restriction in newborns classified as small for gestational age: correlates and risk of neonatal morbidity. Am J Perinatol 2014; 31 (3) 187-194
- 48 Monier I, Blondel B, Ego A, Kaminiski M, Goffinet F, Zeitlin J. Poor effectiveness of antenatal detection of fetal growth restriction and consequences for obstetric management and neonatal outcomes: a French national study. BJOG 2015; 122 (4) 518-527
- 49 Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome?. Ultrasound Obstet Gynecol 2005; 25 (3) 258-264
- 50 Belfort MA, Saade GR, Thom E , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. A randomized trial of intrapartum fetal ECG ST-segment analysis. N Engl J Med 2015; 373 (7) 632-641